The MRI fusion guided prostate biopsy “fuses” MRI scans with real-time ultrasound images of the prostate. This cutting-edge biopsy system allows us here at the Dr. David Samadi Prostate Cancer Center to pinpoint specific tumors within the prostate gland. This information provides the patient with the most optimal treatment plan and best possible outcome in detecting and diagnosing prostate cancer.
Read MoreResearchers at Cancer Research UK have discovered that there are actually five different types of prostate cancer. The researchers say that these five different types of prostate cancer can be distinguished from one another and may even mean different treatments for each type that could be targeted to patients. The study was published in the journal EBioMedicine.
Read MoreHow are the “same” cancers treated differently? Not all gleason scores of 6, 7, or 8+ can be treated equally. How do we individualize the care with the diagnostic tools available to us, when patients present with similar clinicopathologic characteristics?
Read MoreWe've seen a six-fold increase in younger men getting prostate cancer. And if it occurs in younger men, the tumor is more likely to be growing at a rapid rate. Here's what they need to know.
Read MoreResearchers at the University of Michigan have found a previously unknown biomarker that may be significant in diagnosing and treating aggressive prostate cancers. Here's what men need to know.
Read More
New research has emerged these past few weeks on prostate cancer diagnosis, treatment and its genetic root. There's a big debate in how prostate cancer should be treated in older verses younger men. Now, a new study is showing where the gaps are and in particular when we find aggressive prostate cancer, how it should be treated.
Read MoreWe already know family history is a major risk factor for prostate cancer but new research may reveal the root of the role genetics plays in the development of the disease.
Read More
